Pafolacianine: Side Effects, Uses & Monitoring
Facts extracted from current FDA product labeling for Pafolacianine. Educational only — not medical advice.
Labeled uses
CYTALUX is indicated as an adjunct for intraoperative identification of: Malignant lesions in adult patients with ovarian cancer. Malignant and non-malignant pulmonary lesions in adult patients with known or suspected cancer in the lung.
Source: FDA labeling via NIH DailyMed (set d21952b9…). Not affiliated with FDA or NIH.
Medical disclaimer: Always consult a qualified healthcare professional about any medication.